10x Genomics, Inc.

TXG· NASDAQ· Health Care· Health Care Equipment & Services

$76.97+5.90%

2026-09-17

Financials

Valuation Metrics

10x Genomics, Inc.'s Market Cap is $9.77B. At end of 2025 it was $2.07B. Ranked #939 of 3,121 in US market (top 30%), #302 of 1,463 on NASDAQ (top 21%), #67 of 205 in Health Care Equipment & Services (top 33%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$9.77B	US#939/3,121 Sec#67/205
Revenue	$617M	US#2,168/3,121 Sec#134/205
Net Income	$-75M	US—/3,121 Sec—/205
Total Assets	$1.03B	US#2,468/3,121 Sec#130/205
Net Assets	$826M	US#1,902/3,121 Sec#102/205
Value
P/B	11.84x	US#2,680/3,121 Sec#172/205
P/S	15.84x	US#2,806/3,121 Sec#193/205
EV/EBITDA	333.81x	US#2,504/3,121 Sec#144/205
FCF Yield	1.24%	US#2,155/3,121 Sec#127/205
Profitability
ROE	-9.10%	US#2,352/3,121 Sec#133/205
ROA	-7.29%	US#2,603/3,121 Sec#149/205
Op. Margin	-14.33%	US#2,578/3,121 Sec#162/205
Revenue Growth	-4.28%	US#2,457/3,121 Sec#182/205
Financial Health
Debt Ratio	24.77%	US#275/3,121 Sec#27/205
Total Debt	$79M	US#2,501/3,121 Sec#144/205
FCF	$121M	US#1,655/3,121 Sec#96/205
Cash	$503M	US#1,074/3,121 Sec#62/205
Current Ratio	5.69x	US#414/3,121 Sec#31/205
Net Debt/EBITDA	-15.13x	US#25/3,121 Sec#3/205
Performance
1Y Return	498.52%	US#12/3,121 Sec#1/205
1M Return	38.36%	US#22/3,121 Sec#5/205
From 52W High	-3.72%	US#211/3,121 Sec#29/205
1Y MDD	-28.03%	US#1,280/3,121 Sec#50/205
Trading
Volume	3,089,861 shares	US#571/3,121 Sec#29/205
Trading Value	$239M	US#388/3,121 Sec#30/205
Per Share
EPS	$-0.59	US—/3,121 Sec—/205
BPS	$6.50	US#2,146/3,121 Sec#131/205